Interleukin-2: sunrise for immunotherapy?
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*; D007694:Killer Cells, Natural / Q000502:physiology; D008545:Melanoma / Q000628:therapy; D013602:T-Lymphocytes, Cytotoxic / Q000502:physiology
D007376:Interleukin-2